Topaz Clinical Research

Executive Summary

Topaz Clinical Research, founded in 2010 and headquartered in New York, is a US-based clinical research organization (CRO) providing comprehensive trial management and patient recruitment services to pharmaceutical and biotechnology companies. With over a decade of experience, the company supports the entire drug development process from planning through execution. As a privately held firm, Topaz focuses on delivering efficient and reliable clinical trial services, leveraging its expertise to help clients navigate the complexities of drug development. The global CRO market is poised for steady growth, driven by increasing R&D outsourcing and the need for specialized services. Topaz's established presence and focus on patient recruitment position it well to capture opportunities, but it faces intense competition from larger CROs. The company's ability to win new contracts and expand its service offerings will be key to its growth trajectory.

Upcoming Catalysts (preview)

• Q3 2026New contract wins with mid-tier pharma companies60% success
• Q4 2026Expansion of patient recruitment technology platform50% success
• Q2 2026Strategic partnership with a biotechnology firm for rare disease trials40% success